INFECTIOUS DISEASE SEMINAR

Schedule for Spring 2024

This schedule was last updated on March 19, 2024.

Date Presentations
Jan 17
No Class Top Seminar Home
 
Jan 24
Organizational Meeting -- Via Zoom  Top Seminar Home
 
Jan 31
Rachel Clear   Top Seminar Home
San Juan, E., Araya-Donoso, R., Sierra-Rosales, C. et al. Humans as blood-feeding sources in sylvatic triatomines of Chile unveiled by next-generation sequencing. Parasites Vectors 16, 225 (2023). https://doi.org/10.1186/s13071-023-05841-x 
Feb 7
Zoe Jacobs  Top Seminar Home
Andronescu LR, Sharma A, Peterson I, Kachingwe M, et al. (2022) The Effect of Intermittent Preventive Treatment of Malaria During Pregnancy and Placental Malaria on Infant Risk of Malaria. J Infect Dis. 225(2):248-256. doi: 10.1093/infdis/jiab351.  
Feb 14
Ash Wednesday -- No Class Top Seminar Home
 
Feb 21
McKenna Howell  Top Seminar Home
Schneider M, Narciso-Abraham M, Hadl S, et al. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2023 Jun 24;401(10394):2138-2147. doi: 10.1016/S0140-6736(23)00641-4.  
Feb 28
Malcolm MacLean  Top Seminar Home
Anettova L, Sipkova A, Izquierdo-Rodriguez E, Velic V, Modry D. Rat lungworm survives winter: experimental overwintering of Angiostrongylus cantonensis larvae in European slugs. Parasitology. 2023;150(10):950-955. doi:10.1017/S0031182023000781 
Rivory P, Lee R, Slapeta J. Rat lungworm (Angiostrongylus cantonensis) active larval emergence from deceased bubble pond snails (Bullastra lessoni) into water. Parasitology. 2023;150(8):700-704. doi:10.1017/S0031182023000434 
Jacob Ford     
Ismail, R.B.Y., Bozorg-Omid, F., Osei, J.H.N. et al. Predicting the environmental suitability for Anopheles stephensi under the current conditions in Ghana. Sci Rep 14, 1116 (2024). https://doi.org/10.1038/s41598-024-51780-7
Mar 6
Mason Yonge  Top Seminar Home
M Schnell, G Scher, C Yankowski et al. An Inactivated Rabies-based Lassa Fever Virus Vaccine Candidate, LASSARAB, Protects Nonhuman Primates from Lethal Disease, 28 December 2023, Preprint NJP Vaccines (Version 1) available at Research Square https://doi.org/10.21203/rs.3.rs-3673845/v1 
Mar 13
Lizzie Heilmann  Top Seminar Home
Barsosio HC, Madanitsa M, Ondieki ED, et al. Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial. Lancet. 2024 Jan 12:S0140-6736(23)02631-4. doi: 10.1016/S0140-6736(23)02631-4.  
Mar 20
Alyssa Schwinn  Top Seminar Home
G Shrivastava, PC Valenzuela-Leon, AC Chagas, O Kern, K Botello, Y Zhang, et al (2022) Alboserpin, the Main Salivary Anticoagulant from the Disease Vector Aedes albopictus, Displays Anti–FXa-PAR Signaling In Vitro and In Vivo. Immunohorizons 6 (6): 373–383. https://doi.org/10.4049/immunohorizons.2200045 
Mar 27
Spring Break -- No Class Seminar Home
 
Apr 3
Emma Anderson Top Seminar Home
Stewart ATM, Mysore K, Njoroge TM, Winter N, Feng RS, Singh S, James LD, Singkhaimuk P, Sun L, Mohammed A, et al. (2023) Demonstration of RNAi Yeast Insecticide Activity in Semi-Field Larvicide and Attractive Targeted Sugar Bait Trials Conducted on Aedes and Culex Mosquitoes. Insects 14(12):950. https://doi.org/10.3390/insects14120950 
Ola Olajiga     
Dicko A, Ouedraogo JB, Zongo I, Sagara I, Cairns M, Yerbanga RS, et al (2024) Seasonal vaccination with RTS,S/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial. Lancet Infect Dis 24(1):75-86. doi: 10.1016/S1473-3099(23)00368-7
Apr 10
Opeoluwa Akerele  Top Seminar Home
Wong, F., Zheng, E.J., Valeri, J.A. et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature 626, 177-185 (2024). https://doi.org/10.1038/s41586-023-06887-8 
Nikhil Bhagat     
 
Apr 17
Kelvin Clulee  Top Seminar Home
Sprecher VP, Hofmann D, Savathdy V, Xayavong P, Norkhankhame C, Huy R, Khieu V, Sayasone S, Hattendorf J, Keiser J. Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia: a randomised, double-blind, non-inferiority, phase 2b/3 trial. Lancet Infect Dis. 2024 Feb;24(2):196-205. doi: 10.1016/S1473-3099(23)00507-8.
     
Apr 24
  Seminar Home
 
     
 
     
 
May 1
= Monday  Seminar Home
Can be used for presentations if necessary 
May 8
Scheduled Final Exam Seminar Home
Will be used for presentations if necessary

This schedule was last updated on March 19, 2024.